ADVISORY BOARD

Review

Reviewing the guidelines for the Saudi Network for Clinical Trials.

Contribute

Contributing to the development and review of the policies to support the Saudi Network for Clinical Trials

Advise

Advising on best practices of similar international institutions

Participate

Participating and promoting the conduct of high standards clinical trials in the Kingdom of Saudi Arabia.

Help

Helping promote the reputation of the Saudi Network for Clinical Trials locally, regionally, and internationally.

OUR BOARD MEMBERS

Dr. Ahmed Alaskar, KAIMRC/MNG-HA (Chairman)
Dr. Abdelali Haoudi, KAIMRC/MNG-HA (Vice Chairman)
Dr. Majed Al Jeraisay, KAIMRC/MNG-HA (Member)
Dr. Ahmed AlGhamdi, Saudi Food and Drug Authority (Member)
Dr. Saleh AlGhamdi, King Fahad Medical City (Member)
Dr. Mohammed Alkelya, Saudi Health Council (Member)
Dr. Riad El Fakih , King Faisal Specialist Hospital and Research Center (Member)
Dr. Mahmoud Mosli , King Abdulaziz University Hospital (Member)
Dr. Fatima Cassim , AstraZeneca (Member)
Dr. Hani Al-Hashmi, Pfizer Saudi (Member)
Prof. Tariq Alhawassi, King Saud University (Member)
Dr. Paolo Martini, Moderna, Member
Dr. Mohamed Abdulkader, Sanofi, Member
Dr. Mona Obaid, Eli Lilly, Member
Dr. Rania Ashraf, J&J, Member
Dr. Dana Alajlani, SANOFI, Member